Estrella Immunopharma Statistics
Share Statistics
Estrella Immunopharma has -
shares outstanding. The number of shares has increased by -0.58%
in one year.
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.58% |
| Shares Change (QoQ) | -0.04% |
| Owned by Institutions (%) | n/a |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 3,069 |
| FTD / Avg. Volume | 5.99% |
Short Selling Information
The latest short interest is 2.74K, so 0.01% of the outstanding
shares have been sold short.
| Short Interest | 2.74K |
| Short % of Shares Out | 0.01% |
| Short % of Float | 0.03% |
| Short Ratio (days to cover) | 1 |
Valuation Ratios
The PE ratio is -5.3 and the forward
PE ratio is -2.22.
Estrella Immunopharma's PEG ratio is
-0.23.
| PE Ratio | -5.3 |
| Forward PE | -2.22 |
| PS Ratio | 0 |
| Forward PS | n/a |
| PB Ratio | 9.06 |
| P/FCF Ratio | -2.41 |
| PEG Ratio | -0.23 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Estrella Immunopharma.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.65,
with a Debt / Equity ratio of 0.
| Current Ratio | 24.65 |
| Quick Ratio | 24.65 |
| Debt / Equity | 0 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | undefined |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 1.63K |
| Effective Tax Rate | -0.02% |
Stock Price Statistics
The stock price has increased by -8.1% in the
last 52 weeks. The beta is 0.37, so Estrella Immunopharma's
price volatility has been higher than the market average.
| Beta | 0.37 |
| 52-Week Price Change | -8.1% |
| 50-Day Moving Average | 0.97 |
| 200-Day Moving Average | 1.05 |
| Relative Strength Index (RSI) | 35.56 |
| Average Volume (20 Days) | 51,225 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -7.31M |
| Net Income | -7.31M |
| EBITDA | -7.31M |
| EBIT | -7.31M |
| Earnings Per Share (EPS) | -0.21 |
Full Income StatementBalance Sheet
The company has 4.17M in cash and 0 in
debt, giving a net cash position of 4.17M.
| Cash & Cash Equivalents | 4.17M |
| Total Debt | n/a |
| Net Cash | n/a |
| Retained Earnings | -19.5M |
| Total Assets | 3.74M |
| Working Capital | -753.71K |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -16.07M
and capital expenditures -4, giving a free cash flow of -16.07M.
| Operating Cash Flow | -16.07M |
| Capital Expenditures | -4 |
| Free Cash Flow | -16.07M |
| FCF Per Share | -0.46 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
